Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Stoll

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Fund Raising Management|November 7, 1982
How to budget the fund raising processR E Stoll
Progress in Clinical and Biological Research|January 1, 1987
The preclinical development of biotechnology-derived pharmaceuticals: the PMA perspective. Pharmaceutical Manufacturers AssociationR E Stoll
Toxicologic Pathology|August 26, 1998
Cancer hazard identification: toward simplification and interpretabilityR E Stoll
Environmental and Molecular Mutagenesis|February 15, 2001
Transgenic assays and the identification of carcinogensR Tennant, J Haseman, R E Stoll
Psychopharmacology|May 5, 1976
Barbital alteration of central nervous system sensitivity to hexobarbital in the ratR C Schnell, R E Stoll, T D Prosser
Life Sciences|August 1, 1974
Possible role of pheromones in modifying drug response in the mouseR E Stoll, R M Paolino, W F Bousquet
Toxicologic Pathology|October 21, 1999
Oxymetholone: II. Evaluation in the Tg-AC transgenic mouse model for detection of carcinogensH E Holden, R E Stoll, K T Blanchard
Metabolism: Clinical and Experimental|March 1, 1973
The chick as a laboratory model for the study of estrogen-induced hyperlipidemiaD J Kudzma, P M Hegstad, R E Stoll
Lens and Eye Toxicity Research|January 1, 1990
Post-mortem biochemistry of beagle dog lenses after treatment with Fluvastatin (Sandoz) for 2 years at different dose levelsO Hockwin, M Evans, S A Roberts, et al.
American Journal of Veterinary Research|December 7, 2000
Hemodynamic and electrophysiologic effects of ontazolast in dogsR L Hamlin, T Nakayama, J T Brady, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Fund Raising Management|November 7, 1982
How to budget the fund raising processR E Stoll
Progress in Clinical and Biological Research|January 1, 1987
The preclinical development of biotechnology-derived pharmaceuticals: the PMA perspective. Pharmaceutical Manufacturers AssociationR E Stoll
Toxicologic Pathology|August 26, 1998
Cancer hazard identification: toward simplification and interpretabilityR E Stoll
Environmental and Molecular Mutagenesis|February 15, 2001
Transgenic assays and the identification of carcinogensR Tennant, J Haseman, R E Stoll
Psychopharmacology|May 5, 1976
Barbital alteration of central nervous system sensitivity to hexobarbital in the ratR C Schnell, R E Stoll, T D Prosser
Life Sciences|August 1, 1974
Possible role of pheromones in modifying drug response in the mouseR E Stoll, R M Paolino, W F Bousquet
Toxicologic Pathology|October 21, 1999
Oxymetholone: II. Evaluation in the Tg-AC transgenic mouse model for detection of carcinogensH E Holden, R E Stoll, K T Blanchard
Metabolism: Clinical and Experimental|March 1, 1973
The chick as a laboratory model for the study of estrogen-induced hyperlipidemiaD J Kudzma, P M Hegstad, R E Stoll
Lens and Eye Toxicity Research|January 1, 1990
Post-mortem biochemistry of beagle dog lenses after treatment with Fluvastatin (Sandoz) for 2 years at different dose levelsO Hockwin, M Evans, S A Roberts, et al.
American Journal of Veterinary Research|December 7, 2000
Hemodynamic and electrophysiologic effects of ontazolast in dogsR L Hamlin, T Nakayama, J T Brady, et al.
Pageof 3